Renal ischaemia-reperfusion injury

British Journal of Surgery

Volumn 83, Issue 2, 1996, Pages 162-170

  Weight, S C ^a   Bell, P R F ^a   Nicholson, M L ^a  

^a LEICESTER GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ATRIAL NATRIURETIC FACTOR; FREE RADICAL; IBUPROFEN; ILOPROST; NICARDIPINE; PROSTACYCLIN; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST;

DRUG EFFECT; HUMAN; KIDNEY ISCHEMIA; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW;

FREE RADICALS; GRAFT REJECTION; HUMANS; ISCHEMIA; KIDNEY; NEUTROPHILS; REPERFUSION INJURY;

EID: 0030030418     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1002/bjs.1800830206     Document Type: Review

References (159)

1. Dickstein RA. Reperfusion injury: the role of leukocytes. Perfusion Life February 1990; 34-8.
2. Biemond P, Swaak AJG, Beindorff CM, Koster JF. Superoxide-dependent and -independent mechanisms of iron mobilization from ferritin by xanthine oxidase. Implications for oxygen-free-radical-induced tissue destruction during ischacmia and inflammation. Biochem J 1986; 239: 169-73.
3. Freeman BA, Crapo JD. Biology of disease. Free radicals and tissue injury. Lab Invest 1982; 47: 412-26.
4. Halliwell B. Oxidants and human disease: some new concepts. FASEB J 1987; 1: 358-64.
5. Halliwell B, Gutteridge JMC. Oxygen toxicity, oxygen radicals, transition metals and disease. Biochem J 1984; 219: 1-14.
6. McCord JM. Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med 1985; 312: 159-63.
7. Grace PA. Ischaemia-reperfusion injury. Br J Surg 1994; 81: 637-47.
8. Radi R, Beckman JS, Bush KM, Freeman BA. Peroxynitrite-induced membrane lipid peroxidation: the cytotoxic potential of superoxide and nitric oxide. Arch Biochem Biophys 1991; 288: 481-7.
9. Beckman JS. Ischaemic injury mediator. Nature 1990; 345: 27-8 (Letter).
10. Bucher JR, Tien M, Aust SD. The requirement for ferric in the initiation of lipid peroxidation by chelated ferrous iron. Biochem Biophys Res Cummun 1983; 111: 777-84.
11. Reilly PM, Schiller HJ, Bulkley GB. Pharmacologic approach to tissue injury mediated by free radicals and other reactive oxygen metabolites. Am J Surg 1991; 161: 488-503.
12. Turrens JF, Boveris A. Generation of superoxide anion by the NADH dehydrogenase of bovine heart mitochondria. Biochem J 1980; 191: 421-7.
13. McCord JM, Fridovich I. Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprcin). J Biol Chem 1969; 244: 6049-55.
14. Green CJ, Gower JD, Healing G, Cotterill LA, Fuller BJ, Simpkin S. The importance of iron, calcium and free radicals in reperfusion injury: an overview of studies in ischaemic rabbit kidneys. Free Radic Res Commun 1989; 7: 255-64.
15. Mandel LJ, Takano T, Soltoff SP, Murdaugh S. Mechanisms whereby exogenous adenine nucleotides improve rabbit renal proximal function during and after anoxia. J Clin Invest 1988; 81: 1255-64.
16. Wilson DR, Arnold PE, Burke TJ, Schrier RW. Mitochondrial calcium accumulation and respiration in ischemic acute renal failure in the rat. Kidney Int 1984; 25: 519-26.
17. Snowdowne KW, Freudenrich CC, Borle AB. The effects of anoxia on cytosolic free calcium, calcium fluxes, and cellular ATP levels in cultured kidney cells. J Biol Chem 1985; 260: 11 619-26.
18. McCord JM, Fridovich I. The reduction of cytochrome c by milk xanthine oxidase. J Biol Chem 1968; 243: 5753-60.
19. Parks DA, Granger DN, Bulkley GB, Shah AK. Soybean trypsin inhibitor attenuates ischemic injury to the feline small intestine. Gastroenterology 1985; 89: 6-12.
20. Bulkley GB. Endothelial xanthine oxidase: a radical transducer of inflammatory signals for reticuloendothelial activation. Br J Surg 1993; 80: 684-6.
21. Friedl HP, Till GO, Ryan US, Ward PA. Mediator-induced activation of xanthine oxidase in endothelial cells. FASEB J 1989; 3: 2512-18.
22. Baker MS, Gebicki JM. The effect of pH on yields of hydroxyl radicals produced from superoxide by potential biological iron chelators. Arch Biochem Biophys 1986; 246: 581-8.
23. Biemond P, van Eijk HG, Swaak AJG, Koster JF. Iron mobilization from ferritin by superoxide derived from stimulated polymorphonuclear leukocytes. Possible mechanism in inflammation diseases. J Clin Invest 1984; 73: 1576-9.
24. Angel MF, Narayanan K, Swartz WM et al. The etiologic role of free radicals in hematoma-induced flap necrosis. Plastic Reconstr Surg 1986; 77: 795-803.
25. 2 inhibition decouples lung injury from gut ischemia-reperfusion. Surgery 1992; 112: 173-80.
26. Klausner JM, Paterson IS, Valeri CR, Shepro D, Hechtman HB. Limb ischemia-induced increase in permeability is mediated by leukocytes and leukotrienes. Ann Surg 1988; 208: 755-60.
27. Klausner JM, Paterson IS, Kobzik L et al. Vasodilating prostaglandins attenuate ischemic renal injury only if thromboxane is inhibited. Ann Surg 1989; 209: 219-24.
28. Klausner JM, Paterson IS, Mannick JA, Valeri R, Shepro D, Hechtman HB. Reperfusion pulmonary edema. JAMA 1989; 261: 1030-5.
29. 2 moderates permeability after limb ischemia. Ann Surg 1985; 202: 642-6.
30. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979; 95: 351-8.
31. Fuld R, Spar B, Urbaitis BK. Measurement of malondealdehyde in kidney following ischemia and reflow. Kidney Int 1986; 29: 301 (Abstract).
32. McCoy RN, Hill KE, Ayon MA, Stein JH, Burk RF. Oxidant stress following renal ischemia: changes in the glutathione redox ratio. Kidney Int 1988; 33: 812-17.
33. Ratych RE, Chuknyiska RS, Bulkley GB. The primary localization of free radical generation after anoxia/ reoxygenation in isolated endothelial cells. Surgery 1987; 102: 122-31.
34. Hernandez LA, Grisham MB, Twohig B, Arfors KE, Granger N. Role of neutrophils in ischemia-reperfusion injury. Federation Proceedings 1987; 46: 1124 (Abstract).
35. Lewis MS, Whatley RE, Cain P, McIntyre TM, Prescott SM, Zimmerman GA. Hydrogen peroxide stimulates the synthesis of platelet-activating factor by endothelium and induces endothelial cell-dependent neutrophil adhesion. J Clin Invest 1988; 82: 2045-55.
36. Beekhuizen H, van Furth R. Monocyte adherence to human vascular endothelium. J Leukoc Biol 1993; 54: 363-78.
37. Windsor ACJ, Mullen PG, Fowler AA, Sugerman HJ. Role of the neutrophil in adult respiratory distress syndrome. Br J Surg 1993; 80: 10-17.
38. Nathan C, Srimal S, Farber C et al. Cytokine-induced respiratory burst of human neutrophils: dependence on extracellular matrix proteins and CD11/CD18 integrins. J Cell Biol 1989; 109: 1341-9.
39. Lawrence MB, Springer TA. Leukocytes roll on a selectin at physiologic flow rates: distinction from and prerequisite for adhesion through integrins. Cell 1991; 65: 859-73.
40. 2 integrins in vivo. Proc Natl Acad Sci U S A 1991; 88: 7538-42.
41. Baggiolini M, Walz A, Kunkel SL. Neutrophil-activating peptide-1/interleukin-8, a novel cytokine that activates neutrophils. J Clin Invest 1989; 84: 1045-9.
42. Van Thiel DH, Sakr M, Zetti G, McClain C. FK 506 reduces the injury experienced following renal ischemia and reperfusion. Ren Fail 1992; 14: 285-8.
43. 1, granulocyte-macrophage colony-stimulating factor, interleukin-2, and interleukin-10. Transplantation 1995; 59: 565-72.
44. Bevilacqua MP, Stengelin S, Gimbrone MA Jr, Seed B. Endothelial leukocyte adhesion molecule 1: an inducible receptor for neutrophils related to complement regulatory proteins and lectins. Science 1989; 243: 1160-5.
45. Weiss SJ. Tissue destruction by neutrophils. N Engl J Med 1989; 320: 365-76.
46. Marletta MA, Yoon PS, Iyengar R, Leaf CD, Wishnok JS. Macrophage oxidation of L-arginine to nitrite and nitrate: nitric oxide is an intermediate. Biochemistry 1988; 27: 8706-11.
47. Bassenge E. Clinical relevance of endothelium-derived relaxing factor (EDRF). Br J Clin Pharmacol 1992; 34(Suppl 1): 37-42S.
48. Bagge U, Amundson B, Lauritzen C. White blood cell deformability and plugging of skeletal muscle capillaries in hemorrhagic shock. Acta Physiol Scand 1980; 180: 159-63.
49. Worthen GS, Schwab B III, Elson EL, Downey GP. Mechanics of stimulated neutrophils: cell stiffening induces retention in capillaries. Science 1989; 245: 183-6.
50. Afors KE, Lundberg C, Lindbom L, Lundberg K, Beatty PG, Harlan JM. A monoclonal antibody to the membrane glycoprotein complex CD 18 inhibits polymorphonuclear leukocyte accumulation and plasma leakage in vivo. Blood 1987; 69: 338-40.
51. Carden DL, Smith JK, Korthius RJ. Neutrophil-mediated microvascular dysfunction in postischemic canine skeletal muscle. Role of granulocyte adherence. Circ Res 1990; 66: 1436-44.
52. Simpson PJ, Todd RF III, Fantone JC, Mickelson JK, Griffin JD, Lucchesi BR. Reduction of experimental canine myocardial reperfusion injury by a monoclonal antibody (anti-Mo1, anti-CD11b) that inhibits leukocyte adhesion. J Clin Invest 1988; 81: 624-9.
53. Thornton MA, Winn R, Alpers CE, Zager RA. An evaluation of the neutrophil as a mediator of in vivo renal ischemic-reperfusion injury. Am J Pathol 1989; 135: 509-15.
54. Klausner JM, Paterson IS, Goldman G et al. Postischemic renal injury is mediated by neutrophils and leukotrienes. Am J Physiol 1989; 256: F794-802.
55. Paller MS. Effect of neutrophil depletion on ischemic renal injury in the rat. J Lab Clin Med 1989; 113: 379-86.
56. Pearl JM, Drinkwater DC, Laks H, Capouya ER, Gates RN. Leukocyte-depleted reperfusion of transplanted human hearts: a randomized, double-blind clinical trial. J Heart Lung Transplant 1992; 11: 1082-92.
57. Pearl JM, Drinkwater DC Jr, Laks H, Stein DG, Capouya ER, Bhuta S. Leukocyte-depleted reperfusion of transplanted human hearts prevents ultrastructural evidence of reperfusion injury. J Surg Res 1992; 52: 298-308.
58. Lerman A, Burnett JC Jr. Intact and altered endothelium in regulation of vasomotion. Circulation 1992; 86(Suppl II): 12-19.
59. Parrella MA, Hildebrand FL Jr, Margulics KB, Burnett JC Jr. Endothelium-derived relaxing factor in regulation of basal cardiopulmonary and renal function. Am J Physiol 1991; 261: R323-8.
60. Lüscher TF, Yang Z, Tschudi M et al. Interaction between endothelin-1 and endothelium-derived relaxing factor in human arteries and veins. Circ Res 1990; 66: 1088-94.
61. Yanagisawa M, Kurihara H, Kimura S et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988; 332: 411-15.
62. Vane JR, Änggård EE, Botting RM. Regulatory functions of the vascular endothelium. N Engl J Med 1990; 323: 27-36.
63. Kourembanas S, Marsden PA, McQuillan LP, Faller DV. Hypoxia induces endothelin gene expression and secretion in cultured human endothelium. J Clin Invest 1991; 88: 1054-7.
64. López-Farré A, Riesco A, Espinosa G et al. Effect of endothelin-1 on neutrophil adhesion to endothelial cells and perfused heart. Circulation 1993; 88: 1166-71.
65. Rubin BB, Smith A, Liauw S, Isenman D, Romaschin AD, Walker PM. Complement activation and white cell sequestration in postischacmic skeletal muscle. Am J Physiol 1990; 259: H525-31.
66. Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987; 327: 524-6.
67. Salazar FJ, Pinilla JM, López F, Romero JC, Quesada T. Renal effects of prolonged synthesis inhibition of endothelium-derived nitric oxide. Hypertension 1992; 20: 113-17.
68. Billiar TR, Nitric oxide. Novel biology with clinical relevance. Ann Surg 1995; 221: 339-49.
69. Ujiie K, Yuen J, Hogarth L, Danziger R, Star RA. Localization and regulation of endothelial NO synthase mRNA expression in rat kidney. Am J Physiol 1994; 267: F296-302.
70. Lowenstein CJ, Snyder SH. Nitric oxide, a novel biologic messenger. Cell 1992; 70: 705-7.
71. Nishida K, Harrison DG, Navas JP et al. Molecular cloning and characterization of the constitutive bovine aortic endothelial cell nitric oxide synthase. J Clin Invest 1992; 90: 2092-6.
72. Lamas S, Marsden PA, Li GK, Tempst P, Michel T. Endothelial nitric oxide synthase: molecular cloning and characterization of a distinct constitutive enzyme isoform. Proc Natl Acad Sci U S A 1992; 89: 6348-52.
73. Mundel P, Bachmann S, Bader M et al. Expression of nitric oxide synthase in kidney macula densa cells. Kidney Int 1992; 42: 1017-19.
74. Marsden PA, Schappert KT, Chen HS et al. Molecular cloning and characterization of human endothelial nitric oxide synthase. FEBS Lett 1992; 307: 287-93.
75. Bachmann S, Mundel P. Nitric oxide in the kidney: synthesis, localization, and function. Am J Kidney Dis 1994; 24: 112-29.
76. Johnson RA, Freeman RH. Renin release in rats during blockade of nitric oxide synthesis. Am J Physiol 1994; 266: R1723-9.
77. Sternbergh WC, Makhoul RG, Adelman B. Nitric oxide-mediated, endothelium-dependent vasodilation is selectively attenuated in the postischemic extremity. Surgery 1992; 114: 960-7.
78. Pearson PJ, Schaff HV, Vanhoutte PM. Long-term impairment of endothelium-dependent relaxations to aggregating platelets after reperfusion injury in canine coronary arteries. Circulation 1990; 81: 1921-7.
79. Lieberthal W, Wolf EF, Rennke HG, Valeri CR, Levinsky NG. Renal ischemia and reperfusion impair endothelium-dependent vascular relaxation. Am J Physiol 1989; 256: F894-900.
80. Cristol JP, Thiemermann C, Mitchell JA, Walder C, Vane JR. Support of renal blood flow after ischaemic-reperfusion injury by endogenous formation of nitric oxide and of cyclooxygenase vasodilator metabolites. Br J Pharmacol 1993; 109: 188-94.
81. Kon V, Badr KF. Biological actions and pathophysiologic significance of endothelin in the kidney. Kidney Int 1991; 40: 1-12 (Editorial).
82. Firth JD, Ratcliffe PJ, Raine AEG, Ledingham JGG. Endothelin: an important factor in acute renal failure? Lancet 1988; ii: 1179-82.
83. King AJ, Brenner BM, Anderson S. Endothelin: a potent renal and systemic vasoconstrictor peptide. Am J Physiol 1989; 256: F1051-8.
84. López-Farré A, Gómez-Garre D, Bernabeu F, Montañés I, Millas I, Lopez-Novoa JM. Renal effects and mesangial cell contraction induced by endothelin are mediated by PAF. Kidney Int 1991; 39: 624-30.
85. Schlondorff D, Goldwasser P, Neuwirth R, Satriano JA, Clay KL. Production of platelet-activating factor in glomeruli and cultured glomerular mesangial cells. Am J Physiol 1986; 250: F1123-7.
86. Radomski MW, Palmer RMJ, Moncada S. Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells. Proc Natl Acad Sci U S A 1990; 87: 10 043-7.
87. Juncos LA, Ren YL, Arima S, Ito S. Vasodilator and constrictor actions of platelet-activating factor in the isolated microperfused afferent arteriole of the rabbit kidney. Role of endothelium-derived relaxing factor/nitric oxide and cyclooxygenase products. J Clin Invest 1993; 91: 1374-9.
88. 3 segments. Kidney Int 1978; 14: 31-49.
89. Mason J, Welsch J, Torhorst J. The contribution of vascular obstruction to the functional defect that follows renal ischemia. Kidney Int 1987; 31: 65-71.
90. Mason J, Welsch J, Torhorst J. Protection from ischemic, acute renal failure - the contribution of vascular decongestion. Kidney Int 1985; 27: 234 (Abstract).
91. Bayati A, Nygren K, Källskog Ö, Wolgast M. The long-term outcome of postischemic acute renal failure in the rat. Ren Fail 1992; 14: 333-6.
92. Camazine SM, Ryan GB, Unanue ER, Karnovsky MJ. Isolation of phagocytic cells from the rat renal glomerulus. Lab Invest 1976; 35: 315-26.
93. Linas SL, Whittenburg D, Parsons PE, Repine JE. Mild renal ischemia activates primed neutrophils to cause acute renal failure. Kidney Int 1992; 42: 610-16.
94. Southard JH, Marsh DC, McAnulty JF, Belzer FO. Oxygen-derived free radical damage in organ preservation: activity of superoxide dismutase and xanthine oxidase. Surgery 1987; 101: 566-70.
95. Williams RH, Thomas CE, Navar LG, Evan AP. Hemodynamic and single nephron function during the maintenance phase of ischemic acute renal failure in the dog. Kidney Int 1981; 19: 503-15.
96. Jablonski P, Howden BO, Rae DA, Birrell CS, Marshall VC, Tange J. An experimental model for assessment of renal recovery from warm ischemia. Transplantation 1983; 35: 198-204.
97. Varty K, Veitch PS, Morgan JDT, Bell PRF. Kidney retrieval from asystolic donors: a valuable and viable source of additional organs. Br J Surg 1994; 81: 1459-60.
98. Kootstra G, Wijnen R, van Hooff JP, van der Linden CJ. Twenty percent more kidneys through a non-heart beating program. Transplant Proc 1991; 23: 910-11.
99. Rigotti P, Morpurgo E, Comandella MG et al. Non-heartbeating donors: an alternative organ source in kidney transplantation. Transplant Proc 1991; 23: 2579-80.
100. Calne RY, Pegg DE, Pryse-Davies J, Brown FL. Renal preservation by ice-cooling. An experimental study relating to kidney transplantation from cadavers. BMJ 1963; ii: 651-5.
101. Levy MN. Oxygen consumption and blood flow in the hypothermic, perfused kidney. Am J Physiol 1959; 197: 1111-14.
102. Beizer FO, Southard JH. Principles of solid-organ preservation by cold storage. Transplantation 1988; 45: 673-6.
103. Southard JH, van Gulik TM, Ametani MS et al. Important components of the UW solution. Transplantation 1990; 49: 251-7.
104. Satoh S, Stowe NT, Inman SR, Sankari BR, Magnusson MO, Novick AC. Renal vascular response to vasodilators following warm ischemia and cold storage preservation in dog kidneys. J Urol 1993; 149: 186-9.
105. Hoshino T, Maley WR, Bulkley GB, Williams GM. Ablation of free radical-mediated reperfusion injury for the salvage of kidneys taken from non-heartbeating donors. A quantitative evaluation of the proportion of injury caused by reperfusion following periods of warm, cold and combined warm and cold ischemia. Transplantation 1988; 45: 284-9.
106. Koyama I, Bulkley GB, Williams GM, Im MJ. The role of oxygen free radicals in mediating the reperfusion injury of cold-preserved ischemic kidneys. Transplantation 1985; 40: 590-5.
107. Schneeberger H, Schleibner S, Schilling M et al. Prevention of acute renal failure after kidney transplantation by treatment with rh-SOD: interim analysis of a double-blind placebo-controlled trial. Transplant Proc 1990; 22: 2224-5.
108. Henry TD, Archer SL, Nelson D, Weir EK, From AH. Postischemic oxygen radical production varies with duration of ischemia. Am J Physiol 1993; 264: H1478-84.
109. Wanders A, Akyürek ML, Waltenberger J et al. Impact of ischemia time on chronic vascular rejection in the rat - effects of angiopeptin. Transplant Proc 1993; 25: 2098-9.
110. Kryzmanski M, Müller-Ruchholtz W. Tissue distribution of MHC class II-positive cells, their down-manipulation by monoclonal antibodies and their potential role in organ allograft immunogenicity. Arch Immunol Ther Exp (Warsz) 1992; 40: 177-82.
111. 111In labelled antilymphocyte and anti-class I and II major histocompatibility complex monoclonal antibodies. Transplant Proc 1991; 23: 2143-6.
112. Kryzmanski M, Waaga AM, Ulrichs K et al. The influence of MHC class II antigen blockade by perfusion with a monoclonal antibody on rat renal graft survival. Transpl Int 1991; 4: 180-5.
113. von Gaudecker B, Petersen R, Epstein M, Kaden J, Oesterwitz H. Down-regulation of MHC-expression on dendritic cells in rat kidney grafts by PUVA pretreatment. Adv Exp Med Biol 1993; 329: 495-9.
114. Hauschildt S, Bessler WG, Scheipers P. Engagement of major histocompatibility complex class II molecules leads to nitrite production in bone marrow-derived macrophages. Eur J Immunol 1993; 23: 2988-92.
115. Ioannidis I, Hellinger A, Dehmlow C et al. Evidence for increased nitric oxide production after liver transplantation in humans. Transplantation 1995; 59: 1293-7.
116. Baud L, Ardaillou R. Involvement of reactive oxygen species in kidney damage. Br Med Bull 1993; 49: 621-9.
117. Frei U, Margreiter R, Harms A et al. Preoperative graft reperfusion with a calcium antagonist improves initial function: preliminary results of a prospective randomized trial in 110 kidney recipients. Transplant Proc 1987; 19: 3539-41.
118. Wagner K, Albrecht S, Neumayer H-H. Prevention of posttransplant acute tubular necrosis by the calcium antagonist diltiazem: a prospective randomized study. Am J Nephrol 1987; 7: 287-91.
119. Finn WF. Prevention of ischemic injury in renal transplantation. Kidney Int 1990; 37: 171-82.
120. Van Nueten JM, Vanhoutte PM. Improvement of tissue perfusion with inhibitors of calcium ion influx. Biochem Pharmacol 1980; 29: 479-81.
121. Korthius RJ, Granger DN, Townsley MI, Taylor AE. The role of oxygen-derived free radicals in ischemia-induced increases in canine skeletal muscle vascular permeability. Circ Res 1985; 57: 599-609.
122. Neumayer H-H, Schreiber M, Wagner K. Prevention of delayed graft function by diltiazem and Iloprost. Transplant Proc 1989; 21: 1221-4.
123. Takano T, Soltoff SP, Murdaugh S, Mandel LJ. Intracellular respiratory dysfunction and cell injury in short-term anoxia of rabbit renal proximal tubules. J Clin Invest 1985; 76: 2377-84.
124. Chaudry IH, Clemens MG, Baue AE. Alterations in cell function with ischemia and shock and their correction. Arch Surg 1981; 116: 1309-17.
125. 2 on renal function following ischemia. Am J Physiol 1987; 252: R388-93.
126. Miller WL, Thomas RA, Berne RM, Rubio R. Adenosine production in the ischemic kidney. Circ Res 1978; 43: 390-7.
127. Green CJ, Healing G, Simpkin S, Gower J, Fuller BJ. Allopurinol inhibits lipid peroxidation in warm ischaemic and reperfused rabbit kidneys. Free Radic Res Commun 1989; 6: 329-37.
128. Baker GL, Corry RJ, Autor AP. Oxygen free radical induced damage in kidneys subjected to warm ischemia and reperfusion. Protective effect of superoxide dismutase. Ann Surg 1985; 202: 628-41.
129. Green CJ, Healing G, Simpkin S, Lunec J, Fuller BJ. Increased susceptibility to lipid peroxidation in rabbit kidneys: a consequence of warm ischaemia and subsequent reperfusion. Comp Biochem Physiol [B] 1986; 83: 603-6.
130. Paller MS, Neumann TV. Reactive oxygen species and rat renal epithelial cells during hypoxia and reoxygcnation. Kidney Int 1991; 40; 1041-9.
131. Paller MS, Hoidal JR, Ferris TF. Oxygen free radicals in ischemic acute renal failure in the rat. J Clin Invest 1984; 74: 1156-64.
132. Gamelin LM, Zager RA. Evidence against oxidant injury as a critical mediator of postischemic acute renal failure. Am J Physiol 1988; 255: F450-60.
133. Gryglewski RJ, Palmer RMJ, Moncada S. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature 1986; 320: 454-6.
134. Thomas CE, Morehouse LA, Aust SD. Ferritin and superoxide-dependent lipid peroxidation. J Biol Chem 1985; 260: 3275-80.
135. Menasché P, Pasquier C, Bellucci S, Lorente P, Jaillon P, Piwnica A. Defcroxamine reduces neutrophil-mediated free radical production during cardiopulmonary bypass in man. J Thorac Cardiovasc Surg 1988; 96: 582-9.
136. Menasché P, Antebi H, Alcindor L-G et al. Iron chelation by deferoxamine inhibits lipid peroxidation during cardiopulmonary bypass in humans. Circulation 1990; 82(Suppl IV): 390-6.
137. Green CJ, Healing G, Simpkin S, Lunec J, Fuller BJ. Desferrioxamine reduces susceptibility to lipid peroxidation in rabbit kidneys subjected to warm ischaemia and reperfusion. Comp Biochem Physiol [B] 1986; 85: 113-17.
138. Green CJ, Healing G, Simpkin S, Fuller BJ, Lunec J. Reduced susceptibility to lipid peroxidation in cold ischemic rabbit kidneys after addition of desferrioxamine, mannitol, or uric acid to the flush solution. Cryobiology 1986; 23: 358-65.
139. Hallaway PE, Eaton JW, Panter SS, Hedlund BE. Modulation of deferoxamine toxicity and clearance by covalent attachment to biocompatible polymers. Proc Natl Acad Sci U S A 1989; 86: 10 108-12.
140. Paller MS, Hedlund BE. Role of iron in postischemic renal injury in the rat. Kidney Int 1988; 34: 474-80.
141. Pavlock GS, Southard JH, Lutz MF, Belzer JP, Belzer FO. Effects of mannitol and chlorpromazine pretreatment of rabbits on kidney mitochondria following in vivo ischemia and reflow. Life Sci 1981; 29: 2667-72.
142. Kirschner RE, Fantini GA. Role of iron and oxygen-derived free radicals in ischemia-reperfusion injury. J Am Coll Surg 1994; 179: 103-17.
143. Homer-Vanniasinkam S, Hardy SC, Gough MJ. Reversal of the post-ischaemic changes in skeletal muscle blood flow and viability by a novel inhibitor of lipid peroxidation. Eur J Vasc Surg 1993; 7: 41-5.
144. 2 moderate postischemic renal failure. Surgery 1985; 98: 207-12.
145. 2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc Natl Acad Sci U S A 1990; 87: 9383-7.
146. 2 receptors. J Clin Invest 1992; 90: 136-41.
147. Neumayer H-H, Wagner K, Preuschof L, Stanke H, Schultze G, Molzahn M, Amelioration of postischemic acute renal failure by prostacyclin analogue (Iloprost): long-term studies with chronically instrumented conscious dogs. J Cardiovasc Pharmacol 1986; 8: 785-90.
148. Suzuki S, Nakamura S, Koizumi T et al. The beneficial effect of a prostaglandin L analog on ischemic rat liver. Transplantation 1991; 52: 979-83.
149. Paterson IS, Klausner JM, Pugatch R et al. Non-cardiogenic pulmonary edema after abdominal aortic aneurysm surgery. Ann Surg 1989; 209: 231-6.
150. Droy-Lefaix MT, Drouet Y, Geraud G, Hosford D, Braquet P. Superoxide dimutase (SOD) and the PAF-antagonist (BN 52021) reduce small intestinal damage induced by ischemia-reperfusion. Free Radic Res Commun 1991; 12-13: 725-35.
151. Torras J, Bordalba JR, Seron D et al. Protective effect of the PAF antagonist BN 52021 in an experimental renal warm ischemia model. Transpl Int 1993; 6: 236-8.
152. Kon V, Yoshioka T, Fogo A, Ichikawa I. Glomerular actions of endothelin in vivo. J Clin Invest 1989; 83: 1762-7.
153. Mandel LJ, Schnellmann RG, Jacobs WR. Intracellular glutathione in the protection from anoxic injury in renal proximal tubules. J Clin Invest 1990; 85: 316-24.
154. de Bold AJ. Atrial natriuretic factor: a hormone produced by the heart. Science 1985; 230: 767-70.
155. Shaw SG, Weidmann P, Hodler J, Zimmermann A, Paternostro A. Atrial natriuretic peptide protects against acute ischemic renal failure in the rat. J Clin Invest 1987; 80: 1232-7.
156. Schafferhans K, Heidbreder E, Grimm D, Heidland A. Norepinephrine-induced acute renal failure: beneficial effects of atrial natriuretic factor. Nephron 1986; 44: 240-4.
157. Conger JD, Falk SA, Yuan BH, Schrier RW. Atrial natriuretic peptide and dopamine in a rat model of ischemic acute renal failure. Kidney Int 1989; 35: 1126-32.
158. Conger JD, Falk SA, Hammond WS. Atrial natriuretic pcptide and dopamine in established acute renal failure in the rat. Kidney Int 1991; 40: 21-8.
159. Bulkley GB. Free radical-mediated reperfusion injury: a selective review. Br J Cancer 1987; 55(Suppl VIII): 66-73.